Efp as a new molecular target for breast cancer therapy

Anticancer Drugs. 2003 Jan;14(1):1-2. doi: 10.1097/00001813-200301000-00001.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics
  • Breast Neoplasms / metabolism
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism*
  • Drug Delivery Systems / methods*
  • Female
  • Genetic Therapy / methods
  • Humans
  • Transcription Factors / genetics
  • Transcription Factors / metabolism*
  • Tripartite Motif Proteins
  • Ubiquitin-Protein Ligases

Substances

  • DNA-Binding Proteins
  • Transcription Factors
  • Tripartite Motif Proteins
  • TRIM25 protein, human
  • Ubiquitin-Protein Ligases